Artal Group S.A. Morphic Holding, Inc. Transaction History

Artal Group S.A.

$1.86 Billion
Q1 2024

A detailed history of Artal Group S.A. transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Artal Group S.A. holds 2,213,188 shares of MORF stock, worth $74.2 Million. This represents 4.2% of its overall portfolio holdings.

Number of Shares

2,213,188

Previous 2,213,188 -0.0%

Holding current value

$74.2 Million

Previous $77.9 Million -0.0%

% of portfolio

4.2%

Previous 4.2%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$26.64 - $40.31 $2 Million - $3.02 Million	75,000 Added 3.51%	2,213,188 $77.9 Million
Q3 2023 Nov 13, 2023	SELL	$21.33 - $59.42 $38,543 - $107,371	-1,807 Reduced 0.08%	2,138,188 $49 Million
Q2 2023 Aug 11, 2023	BUY	$34.33 - $62.11 $11.2 Million - $20.3 Million	326,046 Added 17.97%	2,139,995 $123 Million
Q1 2023 May 12, 2023	SELL	$26.01 - $48.69 $8.74 Million - $16.4 Million	-336,051 Reduced 15.63%	1,813,949 $68.3 Million
Q3 2022 Nov 14, 2022	BUY	$22.23 - $33.37 $11.1 Million - $16.7 Million	500,000 Added 30.3%	2,150,000 $60.8 Million

Q1 2022 May 12, 2022	BUY	$36.25 - $52.02 $2.35 Million - $3.38 Million	64,951 Added 4.1%	1,650,000 $66.2 Million
Q3 2021 Nov 12, 2021	SELL	$53.61 - $67.5 $12.6 Million - $15.8 Million	-234,137 Reduced 12.87%	1,585,049 $89.8 Million
Q1 2021 May 14, 2021	BUY	$29.77 - $84.85 $4.99 Million - $14.2 Million	167,500 Added 10.14%	1,819,186 $115 Million
Q3 2020 Nov 13, 2020	SELL	$22.51 - $30.11 $393,925 - $526,925	-17,500 Reduced 1.05%	1,651,686 $45.2 Million
Q2 2020 Aug 14, 2020	SELL	$12.65 - $29.57 $1.9 Million - $4.44 Million	-150,000 Reduced 8.25%	1,669,186 $45.2 Million
Q3 2019 Nov 14, 2019	BUY	$17.46 - $29.05 $23 Million - $38.3 Million	1,319,186 Added 263.84%	1,819,186 $32.9 Million
Q2 2019 Aug 09, 2019	BUY	$18.0 - $19.82 $9 Million - $9.91 Million	500,000 New	500,000 $9.91 Million

Others Institutions Holding MORF

# of Institutions

142

Shares Held

37.9M

Call Options Held

13.5K

Put Options Held

190K

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.29B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.

Account